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ABSTRACT
Objective: Cardiometabolic risk factors such as overweight/
obesity, hyperlipidemia, diabetes, and hypertension are prone
to cluster together in the same individual and result in an
elevated risk of cardiovascular disease and mortality. The
purpose of this study was to examine and quantify the impact
of cardiometabolic risk factor clusters independent of heart
disease on productivity in a nationally representative sample
of US adults.
Methods: The current study estimated the impact of cardi-
ometabolic risk factor clusters on missed work days and
bed days, controlling for sociodemographic characteristics,
comorbidity, and smoking status in a nationally representa-
tive, pooled 2000 and 2002 Medical Expenditure Panel
Survey sample. Cardiometabolic risk factor clusters included
BMI  25 and two of the following three: diabetes, hyper-
lipidemia, and/or hypertension. All estimates were expressed
in $US 2005. Sensitivity analyses were conducted to examine
the impact of varying assumptions on the results.
Results: After controlling for differences in sociodemograph-
ics, smoking and comorbidity, individuals with cardiometa-
bolic risk factor clusters missed 179% more work days and
spent 147% more days in bed (in addition to lost work days)
than those without. Lost work days and bed days resulted in
$17.3 billion annually in lost productivity attributable to
cardiometabolic risk factor clusters in the United States. Sen-
sitivity analyses resulted in a range of annual lost productiv-
ity costs from $3.2 to $23.1 billion.
Conclusions: Common cardiometabolic risk factor clusters
have a signiﬁcant deleterious impact on the US economy,
resulting in $17.3 billion in lost productivity.
Keywords: cardiovascular disease, cost and cost analyses,
indirect costs, productivity, risk factors.
Background
It is clear from decades of research that overweight/
obesity, diabetes, hypertension and hyperlipidemia are
prone to cluster together in the same individual and
result in an elevated risk of cardiovascular disease [1,2]
and mortality [3]. Although there is some controversy
about whether common clusters of cardiometabolic
risk factors reﬂect an underlying syndrome thought to
be related to insulin resistance (commonly referred to
as the “metabolic syndrome”), there is clear evidence
of their deleterious impact on health. Metabolic syn-
drome has been shown to increase the risk of cardio-
vascular disease by 1.65 to 1.93 and all-cause
mortality by 1.27 to 1.37, depending on the deﬁnition
[3].
There is an alarming increase in the incidence of
overweight/obesity, diabetes, hypertension, and hyper-
lipidemia in the United States and throughout the
world [4]. This trend, combined with the aging of the
population, will likely result in a dramatic increase in
the prevalence of cardiovascular disease in the future
[4]. The morbidity and mortality attributed to cardio-
vascular disease translates into signiﬁcant lost produc-
tivity and economic cost [5–12]. It is estimated that
cardiovascular disease results in $152 billion in lost
productivity and $242 billion in direct medical expen-
ditures, resulting in a total estimated cost of $394
billion to the US economy in 2005 ($US 2005) [2].
Hence, the economic burden of cardiovascular disease
will likely signiﬁcantly increase in the future.
The increasing incidence of cardiometabolic risk
factor clusters will contribute to this economic burden
because of its higher risk of developing cardiovascular
disease. Nevertheless, in addition to their contribution
to the development of heart disease, cardiometabolic
risk factor clusters may have a deleterious impact on
productivity in their own right before the development
of overt cardiovascular disease. There is a dearth of
data on the impact of cardiometabolic risk factor clus-
ters independent of heart disease on indirect costs in
the United States. The purpose of the current study
was to examine and quantify the impact of cardi-
ometabolic risk factor clusters independent of heart
disease on productivity in a nationally representative
sample of US adults.
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Methods
Data Source
The Medical Expenditure Panel Survey (MEPS) is
cosponsored by the Agency for Healthcare Research
and Quality and the National Center for Health Sta-
tistics. The MEPS Household Component (HC), a
nationally representative survey of the US civilian non-
institutionalized population, collects detailed infor-
mation on demographic characteristics (age, sex, race,
and ethnicity), education, health conditions, smoking
status and missed work days and days spent in bed due
to illness and injury [13]. The MEPS, based on the
sampling frame for the National Health Interview
Survey, provides a nationally representative sample of
the US civilian noninstitutionalized population, with
oversampling of Hispanics and blacks. The current
research used the 2000 and 2002 MEPS public use
data [13]. The 2000 and 2002 data were used to
provide a larger sample and they each contain data on
unique individuals that do not overlap (unlike the
MEPS 2001 data which have panels that overlap with
2000 and 2002), but are equally nationally represen-
tative. The sample design of the MEPS-HC survey
includes stratiﬁcation, clustering, multiple stages of
selection, and disproportionate sampling [14]. The
MEPS sampling weights incorporate adjustment for
the complex sample design and reﬂect survey nonre-
sponse and population totals from the Current Popu-
lation Survey.
The main outcome of interest in the current analysis
was days of work missed due to illness and injury.
Employed individuals were asked in each round how
many days (half-day or more) of work they missed due
to illness or injury. This was a generic question without
reference to any speciﬁc illness or injury. Individuals
were also asked about additional missed days, other
than work or school, in which they spent at least a half
day in bed due to illness or injury. The latter question
was the only measure of lost days for unemployed
individuals.
Cardiometabolic Risk Factor Clusters
Self-reported information from the MEPS-HC survey
was used for the assessment of body mass index (BMI),
medical conditions, and sociodemographic character-
istics. BMI  25 was considered a cardiometabolic
risk factor. BMI was calculated from self-reported
current body weight and height, using the following
formula (from the Centers for Disease Control and
Prevention http://www.cdc.gov/): BMI = [weight in
pounds/(height in inches)2] ¥ 703. Full documentation
is provided on page 97 of the MEPS H60 documenta-
tion ﬁle [13]. Respondents were also asked if they had
ever been diagnosed as having diabetes (excluding ges-
tational diabetes) and if they had been told on two or
more different medical visits that they had high blood
pressure. The MEPS mapped medical conditions to
three-digit ICD-9 codes based on medical and phar-
macy utilization and self-report. Then 259 mutually
exclusive Clinical Classiﬁcation Categories (CCC)
were mapped from ICD-9 codes to provide clinically
homogenous groupings [13,15]. The ICD-9 to CCC
crosswalk is available at: http://www.meps.ahrq [13].
The current research used CCC 053 “Disorders of
Lipid Metabolism” to identify individuals with hyper-
lipidemia. Common clusters of cardiometabolic risk
factors were the focus of the current research. Indi-
viduals were considered to have “cardiometabolic risk
factor clusters” if they had BMI  25 and any two of
the following three risk factors: hypertension, hyper-
lipidemia, and/or diabetes. Based on this criterion, a
dichotomous variable was created to indicate the exist-
ence of cardiometabolic risk factor clusters.
In order to control for confounding in the statistical
analyses, several comorbidity and sociodemographic
characteristics were identiﬁed. The number of chronic
conditions was calculated by adding the total number
of chronic ICD-9 codes reported for each individual,
including cardiovascular disease-related conditions.
From this, a measure of comorbidity burden was con-
structed by adding the number of chronic conditions
(NCC) for each individual. The following variables
were measured categorically: age (18–29; 30–39;
40–49; 50–59; 60–69; 70–79; 80), education (less
than high school degree; high school degree; other
degree; Bachelor’s degree and Master’s or PhD), race
(Caucasian, Black, American Indian or other), ethnic-
ity (Hispanic or non-Hispanic), and smoking status
(Yes/No).
Data Analysis
Negative binomial regression was used to estimate the
impact of cardiometabolic risk factor clusters on
both missed work days and additional bed days. The
number of days was regressed on cardiometabolic risk
factor clusters (Y/N) controlling for age, sex, race,
ethnicity, education, smoking status, and comorbidity
(including cardiovascular comorbidities). The BLS
2005 Average National Hourly Wage across U.S.
Occupations was used to estimate the cost of missed
work days and bed days for national indirect cost
estimates [16]. Because the MEPS does not differenti-
ate between half days and full days missed, it was
assumed that 6 hours of work was missed for each
missed day ($18.70/hour ¥ 6 hours = $112.20/day) for
the baseline analysis.
To calculate the number of missed work days attrib-
utable to cardiometabolic risk factor clusters, the
unadjusted mean number of missed work days for
those without cardiometabolic risk factor clusters was
multiplied by the regression coefﬁcient for cardiometa-
bolic risk factor clusters from the multivariate regres-
sion minus the unadjusted mean number of missed
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work days for those without cardiometabolic risk
factor clusters. Using the number of lost days attribut-
able to cardiometabolic risk factor clusters and the
MEPS sample weights for each individual, the total
cost of missed work days attributable to cardiometa-
bolic risk factor clusters in the United States was cal-
culated. The same method was used to calculate the
total cost and number of bed days attributable to
cardiometabolic risk factor clusters. All analyses incor-
porated the MEPS sampling and variance adjustment
weights to ensure nationally representative estimates.
Sensitivity Analyses
Sensitivity analyses were conducted to examine poten-
tial variation in assumptions. There is uncertainty sur-
rounding the deﬁnition of cardiometabolic risk factor
clusters as discussed above. Hence, additional sensitiv-
ity analyses were conducted on the number of days
missed by number of risk factors. In this analysis, the
number of days was regressed on two dichotomous
variables (BMI  25 and one cardiometabolic risk
factor and BMI  25 and two or more cardiometa-
bolic risk factors) controlling for age, sex, race, ethnic-
ity, education, smoking status, and comorbidity. In
addition, there is uncertainty in the estimation of the
number of hours of work per reported lost day.
Employed individuals were asked in each round how
many days (half-day or more) of work they missed due
to illness or injury. As discussed above, each lost work
day was assumed to consist of 6 hours of lost time
given the lack of speciﬁcity in the MEPS. In the sensi-
tivity analysis, this was varied from 4 hours to 8 hours
of lost time per missed work day. In addition, there is
uncertainty around the value of lost time. Because of
equity considerations, the main analysis used the BLS
2005 Average National Hourly Wage across U.S.
Occupations to value lost time. The sensitivity analysis
included an examination of the target wage (the actual
wage of individuals with cardiometabolic risk factor
clusters as reported in the MEPS). There is also con-
troversy surrounding the value of lost time for non-
working individuals. The sensitivity analysis examines
the inclusion and exclusion of this lost time.
Results
Descriptive statistics for the general adult population
in the MEPS compared with those for individuals with
and without cardiometabolic risk factor clusters are
presented in Table 1. Individuals with cardiometabolic
risk factor clusters are more likely to be poor, less
educated, male, black, aged more than 50 years, and
have more than twice the number of chronic condi-
tions compared with the national average. Likewise,
the prevalence of cardiometabolic risk factor clusters
increases with increasing age, male sex, black race and
lower levels of income and education (Table 2). The
prevalence of individual risk factors, particularly
overweight/obesity, hypertension, and diabetes, appear
to be greater among those with lower levels of educa-
tion and income and older adults. In the unadjusted
univariate analysis, it appears that individuals with
cardiometabolic risk factor clusters miss more work
days due to illness or injury and spend more days in
bed due to illness or injury (other than work or school)
annually when compared with those without cardi-
ometabolic risk factor clusters and to the US average
(Table 3). For example, in the unadjusted descriptive
statistics in Table 3, employed individuals with cardi-
ometabolic risk factor clusters missed an average of
10 days of work annually compared with only 5 days
for those without.
In the multivariate regression analyses, after con-
trolling for sociodemographic characteristics, smoking
status, and comorbidity, having cardiometabolic risk
factor clusters increased the annual number of missed
work days by a factor of 1.79 per employed individual.
The annual number of additional days, other than
work or school, spent in bed due to illness or injury
was also greater by a factor of 1.47 for those with
cardiometabolic risk factor clusters. The annual
number of lost work days per employed individual and
additional lost days spent in bed (other than missed
work or school) attributable to cardiometabolic risk
factor clusters was 3.6 and 2.5, respectively (Table 4).
These estimates were calculated by multiplying the
unadjusted mean number of days for those without
cardiometabolic risk factor clusters (Table 3, 4.56) by
the negative binomial regression coefﬁcient for cardi-
ometabolic risk factor clusters (Table 4: 1.79) minus
the unadjusted mean number of days for those without
cardiometabolic risk factor clusters (4.56). Using the
national average hourly wage, the annual cost per
person of missed work days or additional bed days was
calculated (Table 4) [16]. The national indirect cost of
lost work days attributable to cardiometabolic risk
factor clusters in the United States totaled $10.3 billion
($US 2005). The indirect cost of additional lost days
spent in bed due to illness and injury (other than work
or school) was $7.1 billion. Hence, the total annual
indirect cost of lost productivity based on these two
measures of lost days due to illness and injury was
$17.3 billion ($US 2005).
Sensitivity Analyses
After controlling for sociodemographic characteristics,
smoking and comorbidity in the multivariate regres-
sion analyses, having BMI  25 and one risk factor
increased the annual number of missed work days by a
factor of 1.23 per employed individual compared with
1.86 for individuals having BMI  25 and two or
more risk factors (the comparison group in this case is
individuals with normal BMI and no risk factors).
Individuals with BMI  25 and one risk factor missed
Indirect Cost of Cardiometabolic Risk Factor Clusters 445
a greater number of additional days, other than work
or school, spent in bed due to illness or injury by a
factor of 1.24 versus 1.56 for those with BMI  25
and two or more risk factors. If the human capital
approach is strictly applied and the lost time of un-
employed individuals (homemakers, retirees, etc.) is
assumed to be of no value, the total indirect cost of lost
work time would equate to $10.3 billion (ignoring the
time lost for unemployed individuals). If each day of
lost work is assumed to equate to 4 hours versus
8 hours, the cost of lost work days and bed days results
in $6.8 billion and $4.7 billion, totaling $11.6 billion
(assuming 4 hours per lost day) versus $13.7 billion
and $9.4 billion, totaling $23.1 billion (assuming
8 hours per lost day), respectively. The targeted wage
for individuals with cardiometabolic risk factor clus-
ters in the MEPS was $8.70 per hour; using this tar-
geted wage results in a cost of lost work days and bed
days of $4.8 billion and $3.3 billion, totaling $8.1
billion. Combining all of these factors, the lowest esti-
mate of the total indirect cost of cardiometabolic risk
factor clusters would be $3.2 billion (assuming only
4 hours per lost day, using the targeted wage to value
lost time and ignoring unemployed individuals’ time),
while the largest estimate would be $23.1 billion
(assuming 8 hours per lost day, using the average wage
in the United States to value lost time and including the
value of lost time for unemployed individuals).
Discussion
The results of this study demonstrate the deleterious
impact of cardiometabolic risk factor clusters on pro-
ductivity independent of overt cardiovascular disease.
After controlling for differences in sociodemographics,
smoking and comorbidity, individuals with cardi-
ometabolic risk factor clusters miss 179% more work
days and spend 147% more days in bed annually than
those without cardiometabolic risk factor clusters.
Previous research has estimated the cost of lost pro-
ductivity of cardiovascular disease to be $34.8 billion
because of morbidity and $116.8 billion because of
mortality (lost future earnings of individuals who die)
in the United States in 2005 [2]. Many other studies
have shown that cardiovascular disease has a profound
negative impact on employment and productivity
[5–12]. There are also studies examining the impact of
diabetes on productivity. Tunceli et al. found that indi-
Table 1 Population characteristics of US adults compared with individuals with and without CMRFC* (Adults >17 years; MEPS 2000
and 2002)
MEPS total (%)
N = 43,221
Without CMRFC* (%)
N = 40,371
With CMRFC* (%)
N = 2850
Income
Poor/negative 10.06 9.97 10.75
Near poor 3.96 3.82 6.13
Low income 12.85 12.57 15.94
Middle income 31.33 31.44 29.77
High income 41.80 42.21 37.41
Level of education
No degree 18.86 18.53 24.30
High school degree 50.87 50.64 52.19
Other degree 6.92 7.02 5.66
Bachelor’s degree 15.76 16.13 11.54
MA or PhD 7.60 7.67 6.32
Age (year)
18–19 3.88 4.33 0.00
20–29 17.98 19.18 0.72
30–39 19.93 21.12 3.19
40–49 20.62 20.98 13.40
50–59 15.81 15.09 24.44
60–69 10.08 8.91 27.43
70–79 7.72 6.73 22.92
80+ 3.99 3.66 7.91
Sex
Female 52.03 51.85 47.20
Male 47.97 48.15 52.80
Race
White 82.99 83.12 82.23
Black 11.65 11.38 14.03
American Indian 0.80 0.79 0.78
Other race 4.56 4.71 2.96
Hispanic ethnicity
Non-Hispanic 88.52 88.44 92.74
Hispanic 11.48 11.56 7.26
Number of chronic conditions 1.80 1.60 5.30
*Cardiometabolic risk factor clusters (CMRFC) = BMI  25 and two of the three following risk factors: diabetes, hypertension, and/or hyperlipidemia.
MEPS, Medical Expenditure Panel Survey.
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viduals with diabetes experienced more work loss days
and work limitations than individuals without diabetes
in the Health and Retirement Study (HRS) [17]. Also
using the HRS, Vijan et al. found diabetes to be a
signiﬁcant predictor of lost income due to early retire-
ment and mortality, increased sick days and disability
[18]. Ramsey et al. found that individuals with diabe-
tes experienced more workplace productivity loss due
to illness compared with those without in a large
employed population [19]. These studies underscore
the negative impact of cardiovascular disease and one
of its main risk factors, diabetes, on productivity. To
the authors’ knowledge, however, there are no studies
that examine the combined impact of common cardi-
ometabolic risk factor clusters independent of car-
diovascular disease. The cardiometabolic risk factor
clusters examined in this analysis commonly cluster
together and are increasing dramatically in prevalence.
The results of the current study demonstrate that these
cardiometabolic risk factor clusters result in $17.3
billion in lost productivity due to morbidity and high-
light the signiﬁcant indirect economic cost of these
common clusters in the United States.
Our analysis is limited in scope to cardiometabolic
risk factor clusters and does not include an examina-
tion of the “metabolic syndrome” strictly deﬁned.
Table 2 CMRFC* and risk factor prevalence by income, education, and demographic characteristics (MEPS 2000 and 2002)
Prevalence of
CMRFC* (%)
Prevalence
BMI 25 (%)
Prevalence of
hyperlipidemia (%)
Prevalence of
hypertension
(%)
Prevalence of
diabetes (%)
Income
Poor/negative 6.76 59.30 6.94 23.43 7.85
Near poor 9.73 61.31 8.02 26.33 11.06
Low income 7.84 60.43 8.16 23.81 8.84
Middle income 5.98 60.12 8.23 19.51 6.09
High income 5.62 57.31 9.52 18.22 4.84
Level of education
No degree 8.08 59.44 7.89 24.96 9.40
High school degree 6.46 60.96 8.68 20.59 6.10
Other degree 5.13 60.51 8.59 18.35 4.92
Bachelor’s degree 4.58 53.86 8.25 14.99 4.68
MA or PhD 5.23 52.88 10.88 18.13 4.05
Age (year)
18–19 0.00 31.36 0.06 0.44 0.66
20–29 0.25 48.17 0.36 2.21 0.87
30–39 1.00 59.92 2.26 6.49 1.96
40–49 4.11 64.97 6.71 15.61 4.15
50–59 9.81 65.96 13.28 29.77 9.39
60–69 17.14 67.41 22.26 43.74 14.83
70–79 18.61 60.85 22.95 51.89 17.30
80+ 12.68 46.96 15.80 55.47 14.30
Sex
Female 5.76 52.08 7.74 21.12 6.29
Male 6.86 66.25 9.57 19.19 6.29
Race
White 6.23 58.66 9.15 19.80 5.90
Black 7.64 68.78 5.48 25.30 9.11
American Indian 6.26 70.00 5.08 21.63 8.66
Other race 4.05 37.63 7.65 13.97 5.90
Hispanic ethnicity
Non-Hispanic 6.58 58.09 9.22 21.20 6.23
Hispanic 4.05 65.68 3.95 12.17 6.79
MEPS (N = 43,221) 6.29 58.95 8.62 20.18 6.29
*Cardiometabolic risk factor clusters (CMRFC) = BMI 25 and two of the three following risk factors: diabetes, hypertension, and/or hyperlipidemia.
BMI, body mass index; MEPS, Medical Expenditure Panel Survey.
Table 3 Annual lost work days and bed days in the United States (MEPS 2000 and 2002)
US average
per person
With CMRFC*
per person
Without CMRFC*
per person
Number of missed work days due to illness/injury† 4.77 10.34 4.56
Additional number of bed days due to illness/injury
(other than work or school)‡
5.92 14.87 5.33
*Cardiometabolic risk factor clusters (CMRFC) = BMI 25 and two of the three following risk factors: diabetes, high blood pressure, and/or hyperlipidemia.
†Only employed individuals included.
‡Employed and unemployed individuals included.
MEPS, Medical Expenditure Panel Survey.
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There have been several different deﬁnitions and con-
troversy surrounding what constitutes the “metabolic
syndrome” [20,21]. In an attempt to unify the different
approaches, the International Diabetes Federation
(IDF) recently offered a new deﬁnition [22]. According
to this deﬁnition, a person with metabolic syndrome
must have central adiposity based on waist circumfer-
ence and two or more of the following four factors:
elevated concentrations of triglycerides, reduced
concentrations of HDL cholesterol, hypertension,
and elevated fasting plasma glucose of more than
100 mg/dL or previously diagnosed type 2 diabetes.
TheMEPS has detailed information about missed work
and condition diagnoses; however, it does not contain
information on laboratory values. Although it would be
interesting to compare our results with those for a
population with the metabolic syndrome by the IDF
deﬁnition, an examination of fasting plasma glucose
levels and the speciﬁc type of dyslipidemia suggested by
the IDF are not possible in the MEPS. The MEPS is the
most detailed nationally representative public health
data source available to examine questions relating to
medical conditions, missed work, income and wages
with detailed demographic and socioeconomic infor-
mation conducive to answering our research question.
Other data sourcesmay havemore detailed information
on undiagnosed conditions such as laboratory plasma
glucose and cholesterol levels; however, it would not
have the requisite information on missed work, wages,
and other characteristics necessary for this analysis. In
addition, there is some controversy about the extent to
which these cardiometabolic risk factor clusters reﬂect
an underlying syndrome related to insulin resistance
(the “metabolic syndrome”) or simply that these risk
factors cluster together [1]. For these reasons, the
current analysis is limited to an examination of the
combined impact of common cardiometabolic risk
factor clusters without assumptions about underlying
pathophysiology and does not include a comparison to
the different deﬁnitions of the metabolic syndrome.
The diabetes (diagnosed) and overweight/obesity
prevalence estimates presented here are consistent with
other survey-based national-level estimates in the
Unite States, while estimates of the prevalence of
hypertension and hyperlipidemia seem lower than
other national estimates based on National Health
and Nutrition Examination Survey (NHANES), most
likely because of the fact that the MEPS is based on
self-report and does not include undiagnosed condi-
tions and laboratory values [23–26]. Although not
comparable to the prevalence of cardiometabolic risk
factor clusters used in this research, previous research
has found the prevalence of metabolic syndrome to
range from 21% to 34% of the US population depend-
ing on the deﬁnition [20,21]. In addition to the differ-
ence in deﬁnitions, the discrepancy in prevalence
estimates may also be due to the inclusion of
laboratory-based impaired fasting glucose, dyslipi-
demia and hypertension versus self-reported diag-
noses. For example, recent estimates suggest that
approximately 35% of individuals with diabetes have
not been diagnosed, and the number of individuals
with impaired fasting glucose is even larger [27].
There are other limitations to this research. The
current analysis uses the national average wage instead
of actual wages (the targeted wage) to determine the
cost of lost time in the baseline analysis. The human
capital approach is often used in economic analyses,
using actual earnings to estimate the opportunity cost
of lost time. Using the targeted wage would result in a
lower value of time lost for women and vulnerable
races than using the national average wage, raising
signiﬁcant equity considerations. Likewise, using
actual wages would imply that there is no value to the
time lost for home producers and retirees or individu-
als who are forced to leave the labor force because of
premature mortality or morbidity caused by disease.
There is some controversy about how to appropriately
value lost time due to the tension between efﬁciency
and equity [28,29]. Using the national average wage,
however, would place an average value on all individu-
al’s time. Although this method has its own limita-
tions, it does provide an estimate of value when
observed or market wages may not accurately reﬂect
the value of an individual’s time. Given this contro-
versy, we also provide an examination of the results
using the targeted wage and assuming no value to lost
Table 4 Multivariate regression results: annual number of
missed work days and bed days and national indirect costs attrib-
utable to cardiometabolic risk factor clusters* in the United
States (MEPS 2000 and 2002)
Attributable to
cardiometabolic
risk factor clusters*
(95% CI)
Percent increase in missed work days† 179% (128%-250%)
Percent increase in additional bed days
(other than work or school)‡
147% (122%-177%)
Number of missed work days per
person†
3.60
Number of additional days spent in
bed (other than work or school)
per person‡
2.50
Annual cost of lost work days per
person
$405§
Annual cost of bed days (other than
work or school) per person
$280§
Annual national cost of missed work $10.3 billion ($US 2005)
Annual national cost of bed days
(other than work or school)
$7.1 billion ($US 2005)
Annual total indirect cost $17.3 billion ($US 2005)
*Cardiometabolic risk factor clusters = BMI 25 and two of the three following risk
factors: diabetes, high blood pressure, and/or hyperlipidemia.
†Only employed individuals included.
‡Employed and unemployed individuals included.
§BLS Average National Hourly Wage across U.S. Occupations [16]
$18.70 ¥ 6 hours ¥Number of Days.
CI, conﬁdence interval; MEPS, Medical Expenditure Panel Survey.
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time for unemployed individuals in the sensitivity
analyses.
There are several reasons why this analysis may
result in an inaccurate estimate of the actual produc-
tivity loss in the United States. First, this analysis does
not attempt to quantify the cost associated with pre-
mature mortality, presenteeism, friction costs, or pre-
mature retirement due to morbidity. Each of these
would signiﬁcantly increase the indirect costs associ-
ated with cardiometabolic risk factor clusters in the
United States. Second, the medical conditions used in
this research are based on self-report and there is evi-
dence that self-reported conditions tend to be under-
reported [30–33]. Overweight respondents also tend
to underestimate their weight and overestimate their
height [34,35]. In addition, the MEPS does not contain
information on laboratory values and thus does not
capture undiagnosed diabetes, hypertension, or hyper-
lipidemia. As discussed above, it is likely that the
number of individuals with undiagnosed diabetes and
impaired fasting glucose is substantially larger than the
population of individuals self-reporting a diagnosis of
diabetes used in this research [27]. As a result, it is
likely that the presence of cardiometabolic risk factor
clusters is underestimated. The indirect cost impact of
cardiometabolic risk factor clusters may be underesti-
mated to a similar degree. Nevertheless, the impact of
“metabolic syndrome” using deﬁnitions that incorpo-
rate undiagnosed conditions may result in a reduced
impact on missed work days per individual compared
with our estimates based on diagnosed conditions (pre-
suming that undiagnosed conditions have less of an
impact than diagnosed conditions). The number of
missed days was also based on self-report, and may
result in over- or under-reporting.
In addition, it is possible that examining each risk
factor individually rather than clusters of risk factors
would be informative. Future research may beneﬁt
from an examination of individual risk factors and
their impact on missed work days and indirect costs. It
may also be informative to examine alternative econo-
metric approaches to estimating lost days and the cost
of lost days. Given the aforementioned limitations, this
analysis has provided a broad sensitivity analysis and
estimates should be considered within the context of
the uncertainty discussed.
Nonetheless, it is clear that cardiometabolic risk
factor clusters represent a signiﬁcant productivity
drain on employers and society. Their prevalence is
increasing signiﬁcantly for almost every group in the
United States [2,36]. These risk factors may be pre-
ventable and public health efforts need to be under-
taken to curb their dramatic rise in prevalence. In
addition, employers would beneﬁt from more aggres-
sive prevention and treatment efforts to halt their
alarming increase and resultant negative impact on
productivity.
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